nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Sibutramine—Hypoglycaemia—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Sibutramine—Loss of consciousness—Etoposide—muscle cancer	0.00146	0.00146	CcSEcCtD
Sibutramine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Sibutramine—Decreased appetite—Vincristine—muscle cancer	0.00146	0.00146	CcSEcCtD
Sibutramine—Cough—Etoposide—muscle cancer	0.00145	0.00145	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00145	0.00145	CcSEcCtD
Sibutramine—Convulsion—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Sibutramine—Hypertension—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Sibutramine—Pain—Vincristine—muscle cancer	0.00143	0.00143	CcSEcCtD
Sibutramine—Constipation—Vincristine—muscle cancer	0.00143	0.00143	CcSEcCtD
Sibutramine—Pain in extremity—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Sibutramine—Osteoarthritis—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Sibutramine—Asthma—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Sibutramine—Chest pain—Etoposide—muscle cancer	0.00142	0.00142	CcSEcCtD
Sibutramine—Eosinophilia—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Sibutramine—Migraine—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Sibutramine—Affect lability—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Sibutramine—Discomfort—Etoposide—muscle cancer	0.0014	0.0014	CcSEcCtD
Sibutramine—Face oedema—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Sibutramine—Hypersensitivity—Dactinomycin—muscle cancer	0.00138	0.00138	CcSEcCtD
Sibutramine—Gastrointestinal pain—Vincristine—muscle cancer	0.00137	0.00137	CcSEcCtD
Sibutramine—Confusional state—Etoposide—muscle cancer	0.00137	0.00137	CcSEcCtD
Sibutramine—Cardiac arrest—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Sibutramine—Anaphylactic shock—Etoposide—muscle cancer	0.00136	0.00136	CcSEcCtD
Sibutramine—Mood swings—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Sibutramine—Infection—Etoposide—muscle cancer	0.00135	0.00135	CcSEcCtD
Sibutramine—Ataxia—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Sibutramine—Asthenia—Dactinomycin—muscle cancer	0.00135	0.00135	CcSEcCtD
Sibutramine—Blood creatinine increased—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Sibutramine—Dysuria—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Sibutramine—Dehydration—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Sibutramine—Thrombocytopenia—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Sibutramine—Tachycardia—Etoposide—muscle cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Body temperature increased—Vincristine—muscle cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Abdominal pain—Vincristine—muscle cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Liver function test abnormal—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Skin disorder—Etoposide—muscle cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Erectile dysfunction—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Dry skin—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Sibutramine—Hyperhidrosis—Etoposide—muscle cancer	0.00131	0.00131	CcSEcCtD
Sibutramine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Sibutramine—Photosensitivity reaction—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Sibutramine—Hypokalaemia—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Sibutramine—Anorexia—Etoposide—muscle cancer	0.00129	0.00129	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Sibutramine—Diarrhoea—Dactinomycin—muscle cancer	0.00128	0.00128	CcSEcCtD
Sibutramine—Pneumonia—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Sibutramine—Depression—Methotrexate—muscle cancer	0.00127	0.00127	CcSEcCtD
Sibutramine—Hypotension—Etoposide—muscle cancer	0.00127	0.00127	CcSEcCtD
Sibutramine—Gastritis—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Sibutramine—Muscular weakness—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Sibutramine—Renal failure—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Sibutramine—Abdominal distension—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Sibutramine—Stomatitis—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Sibutramine—Conjunctivitis—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Sibutramine—Dysphagia—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Sibutramine—Asthma—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Sibutramine—Influenza—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Sibutramine—Hypersensitivity—Vincristine—muscle cancer	0.00123	0.00123	CcSEcCtD
Sibutramine—Eosinophilia—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Sibutramine—Sweating—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Sibutramine—Paraesthesia—Etoposide—muscle cancer	0.00122	0.00122	CcSEcCtD
Sibutramine—Haematuria—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Sibutramine—Dyspnoea—Etoposide—muscle cancer	0.00121	0.00121	CcSEcCtD
Sibutramine—Somnolence—Etoposide—muscle cancer	0.00121	0.00121	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Sibutramine—Epistaxis—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Sibutramine—Asthenia—Vincristine—muscle cancer	0.0012	0.0012	CcSEcCtD
Sibutramine—Vomiting—Dactinomycin—muscle cancer	0.00119	0.00119	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Sibutramine—Rash—Dactinomycin—muscle cancer	0.00118	0.00118	CcSEcCtD
Sibutramine—Decreased appetite—Etoposide—muscle cancer	0.00118	0.00118	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00117	0.00117	CcSEcCtD
Sibutramine—Constipation—Etoposide—muscle cancer	0.00116	0.00116	CcSEcCtD
Sibutramine—Pain—Etoposide—muscle cancer	0.00116	0.00116	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Sibutramine—Haemoglobin—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Sibutramine—Diarrhoea—Vincristine—muscle cancer	0.00115	0.00115	CcSEcCtD
Sibutramine—Haemorrhage—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Sibutramine—Pharyngitis—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Sibutramine—Feeling abnormal—Etoposide—muscle cancer	0.00112	0.00112	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Sibutramine—Nausea—Dactinomycin—muscle cancer	0.00111	0.00111	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Sibutramine—Gastrointestinal pain—Etoposide—muscle cancer	0.00111	0.00111	CcSEcCtD
Sibutramine—Dizziness—Vincristine—muscle cancer	0.00111	0.00111	CcSEcCtD
Sibutramine—Visual impairment—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Sibutramine—Urticaria—Etoposide—muscle cancer	0.00108	0.00108	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Sibutramine—Abdominal pain—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Body temperature increased—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Eye disorder—Methotrexate—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Tinnitus—Methotrexate—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Vomiting—Vincristine—muscle cancer	0.00107	0.00107	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Sibutramine—Rash—Vincristine—muscle cancer	0.00106	0.00106	CcSEcCtD
Sibutramine—Dermatitis—Vincristine—muscle cancer	0.00106	0.00106	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Sibutramine—Headache—Vincristine—muscle cancer	0.00105	0.00105	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Sibutramine—Angiopathy—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Sibutramine—Immune system disorder—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Sibutramine—Chills—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Sibutramine—Alopecia—Methotrexate—muscle cancer	0.00101	0.00101	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Sibutramine—Hypersensitivity—Etoposide—muscle cancer	0.001	0.001	CcSEcCtD
Sibutramine—Malnutrition—Methotrexate—muscle cancer	0.000996	0.000996	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—muscle cancer	0.000996	0.000996	CcSEcCtD
Sibutramine—Nausea—Vincristine—muscle cancer	0.000995	0.000995	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—muscle cancer	0.000993	0.000993	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—muscle cancer	0.000991	0.000991	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000986	0.000986	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—muscle cancer	0.000983	0.000983	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—muscle cancer	0.000976	0.000976	CcSEcCtD
Sibutramine—Dysgeusia—Methotrexate—muscle cancer	0.000975	0.000975	CcSEcCtD
Sibutramine—Asthenia—Etoposide—muscle cancer	0.000974	0.000974	CcSEcCtD
Sibutramine—Back pain—Methotrexate—muscle cancer	0.000963	0.000963	CcSEcCtD
Sibutramine—Pruritus—Etoposide—muscle cancer	0.00096	0.00096	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—muscle cancer	0.000955	0.000955	CcSEcCtD
Sibutramine—Vision blurred—Methotrexate—muscle cancer	0.000939	0.000939	CcSEcCtD
Sibutramine—Diarrhoea—Etoposide—muscle cancer	0.000929	0.000929	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—muscle cancer	0.000926	0.000926	CcSEcCtD
Sibutramine—Ill-defined disorder—Methotrexate—muscle cancer	0.000924	0.000924	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—muscle cancer	0.000924	0.000924	CcSEcCtD
Sibutramine—Anaemia—Methotrexate—muscle cancer	0.000921	0.000921	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—muscle cancer	0.000899	0.000899	CcSEcCtD
Sibutramine—Malaise—Methotrexate—muscle cancer	0.000898	0.000898	CcSEcCtD
Sibutramine—Dizziness—Etoposide—muscle cancer	0.000897	0.000897	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—muscle cancer	0.000895	0.000895	CcSEcCtD
Sibutramine—Vertigo—Methotrexate—muscle cancer	0.000895	0.000895	CcSEcCtD
Sibutramine—Leukopenia—Methotrexate—muscle cancer	0.000892	0.000892	CcSEcCtD
Sibutramine—Chills—Doxorubicin—muscle cancer	0.000889	0.000889	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—muscle cancer	0.000885	0.000885	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—muscle cancer	0.000876	0.000876	CcSEcCtD
Sibutramine—Cough—Methotrexate—muscle cancer	0.000869	0.000869	CcSEcCtD
Sibutramine—Convulsion—Methotrexate—muscle cancer	0.000863	0.000863	CcSEcCtD
Sibutramine—Vomiting—Etoposide—muscle cancer	0.000863	0.000863	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—muscle cancer	0.000862	0.000862	CcSEcCtD
Sibutramine—Rash—Etoposide—muscle cancer	0.000856	0.000856	CcSEcCtD
Sibutramine—Dermatitis—Etoposide—muscle cancer	0.000855	0.000855	CcSEcCtD
Sibutramine—Headache—Etoposide—muscle cancer	0.00085	0.00085	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—muscle cancer	0.00085	0.00085	CcSEcCtD
Sibutramine—Chest pain—Methotrexate—muscle cancer	0.000848	0.000848	CcSEcCtD
Sibutramine—Arthralgia—Methotrexate—muscle cancer	0.000848	0.000848	CcSEcCtD
Sibutramine—Myalgia—Methotrexate—muscle cancer	0.000848	0.000848	CcSEcCtD
Sibutramine—Tension—Doxorubicin—muscle cancer	0.000846	0.000846	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—muscle cancer	0.000845	0.000845	CcSEcCtD
Sibutramine—Discomfort—Methotrexate—muscle cancer	0.000838	0.000838	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—muscle cancer	0.000838	0.000838	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—muscle cancer	0.000834	0.000834	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—muscle cancer	0.000829	0.000829	CcSEcCtD
Sibutramine—Confusional state—Methotrexate—muscle cancer	0.00082	0.00082	CcSEcCtD
Sibutramine—Anaphylactic shock—Methotrexate—muscle cancer	0.000813	0.000813	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—muscle cancer	0.000813	0.000813	CcSEcCtD
Sibutramine—Infection—Methotrexate—muscle cancer	0.000808	0.000808	CcSEcCtD
Sibutramine—Nausea—Etoposide—muscle cancer	0.000806	0.000806	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—muscle cancer	0.0008	0.0008	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—muscle cancer	0.000797	0.000797	CcSEcCtD
Sibutramine—Thrombocytopenia—Methotrexate—muscle cancer	0.000796	0.000796	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—muscle cancer	0.000793	0.000793	CcSEcCtD
Sibutramine—Skin disorder—Methotrexate—muscle cancer	0.00079	0.00079	CcSEcCtD
Sibutramine—Hyperhidrosis—Methotrexate—muscle cancer	0.000786	0.000786	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—muscle cancer	0.000778	0.000778	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—muscle cancer	0.000775	0.000775	CcSEcCtD
Sibutramine—Anorexia—Methotrexate—muscle cancer	0.000775	0.000775	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—muscle cancer	0.000773	0.000773	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—muscle cancer	0.000772	0.000772	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—muscle cancer	0.000762	0.000762	CcSEcCtD
Sibutramine—Hypotension—Methotrexate—muscle cancer	0.00076	0.00076	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—muscle cancer	0.000758	0.000758	CcSEcCtD
Sibutramine—Cough—Doxorubicin—muscle cancer	0.000753	0.000753	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—muscle cancer	0.000747	0.000747	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—muscle cancer	0.000745	0.000745	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000741	0.000741	CcSEcCtD
Sibutramine—Insomnia—Methotrexate—muscle cancer	0.000735	0.000735	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—muscle cancer	0.000734	0.000734	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—muscle cancer	0.000734	0.000734	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—muscle cancer	0.000734	0.000734	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—muscle cancer	0.000732	0.000732	CcSEcCtD
Sibutramine—Paraesthesia—Methotrexate—muscle cancer	0.00073	0.00073	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—muscle cancer	0.000725	0.000725	CcSEcCtD
Sibutramine—Dyspnoea—Methotrexate—muscle cancer	0.000725	0.000725	CcSEcCtD
Sibutramine—Somnolence—Methotrexate—muscle cancer	0.000723	0.000723	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—muscle cancer	0.000718	0.000718	CcSEcCtD
Sibutramine—Dyspepsia—Methotrexate—muscle cancer	0.000716	0.000716	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—muscle cancer	0.00071	0.00071	CcSEcCtD
Sibutramine—Decreased appetite—Methotrexate—muscle cancer	0.000707	0.000707	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—muscle cancer	0.000704	0.000704	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000704	0.000704	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000702	0.000702	CcSEcCtD
Sibutramine—Infection—Doxorubicin—muscle cancer	0.000699	0.000699	CcSEcCtD
Sibutramine—Pain—Methotrexate—muscle cancer	0.000695	0.000695	CcSEcCtD
Sibutramine—Shock—Doxorubicin—muscle cancer	0.000693	0.000693	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000689	0.000689	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—muscle cancer	0.000687	0.000687	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—muscle cancer	0.000684	0.000684	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00068	0.00068	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—muscle cancer	0.000671	0.000671	CcSEcCtD
Sibutramine—Feeling abnormal—Methotrexate—muscle cancer	0.00067	0.00067	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000665	0.000665	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—muscle cancer	0.000658	0.000658	CcSEcCtD
Sibutramine—Urticaria—Methotrexate—muscle cancer	0.000646	0.000646	CcSEcCtD
Sibutramine—Body temperature increased—Methotrexate—muscle cancer	0.000643	0.000643	CcSEcCtD
Sibutramine—Abdominal pain—Methotrexate—muscle cancer	0.000643	0.000643	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000641	0.000641	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—muscle cancer	0.000637	0.000637	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—muscle cancer	0.000632	0.000632	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—muscle cancer	0.000628	0.000628	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—muscle cancer	0.000626	0.000626	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—muscle cancer	0.00062	0.00062	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—muscle cancer	0.000612	0.000612	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000608	0.000608	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—muscle cancer	0.000602	0.000602	CcSEcCtD
Sibutramine—Pain—Doxorubicin—muscle cancer	0.000602	0.000602	CcSEcCtD
Sibutramine—Hypersensitivity—Methotrexate—muscle cancer	0.000599	0.000599	CcSEcCtD
Sibutramine—Asthenia—Methotrexate—muscle cancer	0.000583	0.000583	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—muscle cancer	0.00058	0.00058	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000576	0.000576	CcSEcCtD
Sibutramine—Pruritus—Methotrexate—muscle cancer	0.000575	0.000575	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—muscle cancer	0.000559	0.000559	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—muscle cancer	0.000556	0.000556	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—muscle cancer	0.000556	0.000556	CcSEcCtD
Sibutramine—Diarrhoea—Methotrexate—muscle cancer	0.000556	0.000556	CcSEcCtD
Sibutramine—Dizziness—Methotrexate—muscle cancer	0.000538	0.000538	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—muscle cancer	0.000519	0.000519	CcSEcCtD
Sibutramine—Vomiting—Methotrexate—muscle cancer	0.000517	0.000517	CcSEcCtD
Sibutramine—Rash—Methotrexate—muscle cancer	0.000513	0.000513	CcSEcCtD
Sibutramine—Dermatitis—Methotrexate—muscle cancer	0.000512	0.000512	CcSEcCtD
Sibutramine—Headache—Methotrexate—muscle cancer	0.000509	0.000509	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—muscle cancer	0.000505	0.000505	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—muscle cancer	0.000498	0.000498	CcSEcCtD
Sibutramine—Nausea—Methotrexate—muscle cancer	0.000483	0.000483	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—muscle cancer	0.000482	0.000482	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—muscle cancer	0.000465	0.000465	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—muscle cancer	0.000448	0.000448	CcSEcCtD
Sibutramine—Rash—Doxorubicin—muscle cancer	0.000444	0.000444	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—muscle cancer	0.000443	0.000443	CcSEcCtD
Sibutramine—Headache—Doxorubicin—muscle cancer	0.000441	0.000441	CcSEcCtD
Sibutramine—Nausea—Doxorubicin—muscle cancer	0.000418	0.000418	CcSEcCtD
